Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2020-07-31 Director's Dealing
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 99% confidence The document is titled "Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them" (MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS). This form explicitly details transactions (share transfers/contributions) made by a director (Victor Grifols Roura, listed as 'Consejero') of the issuer (Grifols, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades/transactions by management).
2020-07-31 Spanish
FORM 6-K
Regulatory Filings
2020-07-30 English
1H2020 consolidated interim financial statements
Report Publication Announcement Classification · 99% confidence The document is extremely short (938 characters) and explicitly states 'Re: 1H2020 consolidated interim financial statements' followed by a link to view the document. This structure—announcing the availability of a report via a link rather than containing the full report content—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. The content refers to '1H2020 consolidated interim financial statements,' which would typically be an Interim Report (IR), but since this document is only the notification, RPA is the correct classification.
2020-07-30 English
1H2020 Earnings results
Report Publication Announcement Classification · 99% confidence The document is extremely short (908 characters) and contains an RNS Number (6004U), a date (30 July 2020), and a subject line referencing '1H2020 Earnings results'. Crucially, the body of the text instructs the reader to 'Please click on the following link to view the document' and states the announcement was issued through the Companies Announcement Service of Euronext Dublin. This structure—a brief notification pointing to an external PDF containing the actual results—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content is explicitly an announcement about the release of the 1H2020 Earnings results (which would typically be an ER or IR), and it is merely pointing to the full document, RPA is the most precise fit based on Rule 2 ('MENU VS MEAL' rule). However, given the explicit mention of 'RNS Number' and the service provider information, RNS (Regulatory Filings) is also a strong candidate as a general regulatory announcement wrapper. Since the primary function here is announcing the publication of a report, RPA is selected, though RNS is a close second.
2020-07-30 English
Grifols presenta información correspondiente al primer semestre 2020
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for the first half of 2020 (primer semestre de 2020) for Grifols. It contains comprehensive financial data, including revenue breakdowns by division, EBITDA, net profit, and balance sheet information. It is not a short announcement, but a substantive report of financial performance, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-07-30 Spanish
FORM 6-K
Regulatory Filings
2020-07-20 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.